BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 949182)

  • 1. Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria.
    Ernst EC; Berger S; Barza M; Jacobus NV; Tally FP
    Antimicrob Agents Chemother; 1976 May; 9(5):852-5. PubMed ID: 949182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.
    Eykyn S; Jenkins C; King A; Phillips I
    Antimicrob Agents Chemother; 1973 Jun; 3(6):657-61. PubMed ID: 4790616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro spectrum of the cephalosporins.
    Washington JA
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activity of newer cephalosporins against anaerobic bacteria.
    Chow AW; Bednorz D
    Antimicrob Agents Chemother; 1978 Nov; 14(5):668-71. PubMed ID: 727759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of LY127935.
    Fass RJ
    Antimicrob Agents Chemother; 1979 Oct; 16(4):503-9. PubMed ID: 518080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaerobic bacteria: evaluation of disc susceptibility to four cephalosporins.
    Dubois J; Pechère JC
    Infection; 1978; 6(6):266-70. PubMed ID: 730395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of anaerobes to cefoxitin and other cephalosporins.
    Tally FP; Jacobus NV; Bartlett JG; Gorbach SL
    Antimicrob Agents Chemother; 1975 Feb; 7(2):128-32. PubMed ID: 1137364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of cefoperazone's in vitro antibacterial activity, in comparison with other cephalosporins, on 512 gram-negative bacterial strains.
    Dainelli B; Magni A; Maragoni F; Berlutti F; Thaller MC; Filadoro F
    G Batteriol Virol Immunol; 1981; 74(1-6):8-14. PubMed ID: 6458528
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activity of cefaclor against aerobic and anaerobic bacteria.
    Bach VT; Khurana MM; Thadepalli H
    Antimicrob Agents Chemother; 1978 Feb; 13(2):210-3. PubMed ID: 646343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole.
    Eykyn S; Jenkins C; King A; Phillips I
    Antimicrob Agents Chemother; 1976 Apr; 9(4):690-5. PubMed ID: 1267441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.
    Shemonsky NK; Carrizosa J; Levison ME
    Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of cefcanel versus other oral cephalosporins.
    Chin NX; Gu JW; Neu HC
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):676-82. PubMed ID: 1748125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of anaerobic bacteria to 23 antimicrobial agents.
    Sutter VL; Finegold SM
    Antimicrob Agents Chemother; 1976 Oct; 10(4):736-52. PubMed ID: 984809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria.
    Neu HC; Aswapokee N; Aswapokee P; Fu KP
    Antimicrob Agents Chemother; 1979 Feb; 15(2):273-81. PubMed ID: 426518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.
    Verbist L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):657-63. PubMed ID: 984801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandole.
    Sosna JP; Murray PR; Medoff G
    Antimicrob Agents Chemother; 1978 Dec; 14(6):876-9. PubMed ID: 742875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.